Brief: NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share
01/03/2024 13:32
March 1 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES DEFINITIVE PURCHASE
AGREEMENT FOR
COMMON, UNREGISTERED SHARES AT $0.38 PER SHARE
* NRX PHARMACEUTICALS INC - NRX PHARMACEUTICALS RECEIVED
APPROXIMATELY $1.0 MILLION IN CASH FROM AN EXISTING INVESTOR
Source text for Eikon: ID:nPn81gxvBa
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview